<DOC>
	<DOCNO>NCT02788669</DOCNO>
	<brief_summary>Colorectal cancer ( CRC ) major public health problem France worldwide . CRC third common cancer incidence mortality France . The vast majority cancer adenocarcinomas arise sporadically develop precursor lesion : adenoma . All CCR disease stage prognosis . Various parameter identify factor influence prognosis allow adjustment treatment . The poor histoprognostic factor vessels nerve invasion tumor mucinous adenocarcinoma subtype . At molecular level , presence microsatellite instability ( MSI ) improve prognosis , presence BRAF mutation independent poor prognostic factor . LRP-1 multifunctional endocytic receptor belongs family LDL receptor . It involve clearance matrix protease . A loss expression decrease LRP-1 activity correlate increase aggressiveness cancer cell . This effect demonstrate vitro vesicular thyroid carcinoma LRP-1 blocking . The decrease immunohistochemical expression LRP-1 genomic hepatocellular carcinoma lung adenocarcinomas correlate decrease overall survival . In CRC , one immunohistochemical expression study LRP-1 colonic adenocarcinoma publish date . This study show tumor cell express LRP-1 , nearly half case , weak normal colonic cell . The clinical prognostic impact LRP-1 expression colon cancer association particular molecular morphological profile study date . In work , investigator study immunohistochemical genic expression LRP-1 series colorectal cancer .</brief_summary>
	<brief_title>LRP1 Colon Cancer</brief_title>
	<detailed_description>Colorectal cancer ( CRC ) major public health problem France worldwide . CRC third common cancer incidence mortality France . The vast majority cancer adenocarcinomas arise sporadically develop precursor lesion : adenoma . All CRC disease stage prognosis . Various parameter identify factor influence prognosis allow adjustment treatment . The poor histoprognostic factor presence tumor vessel nerve invasion mucinous adenocarcinoma subtype . At molecular level , presence microsatellite instability ( MSI ) improve prognosis , presence BRAF mutation independent poor prognostic factor . Low density lipoprotein relate Protein Receptor 1 ( LRP-1 ) multifunctional endocytic receptor belongs family LDL receptor . He involve clearance enzyme responsible degradation extracellular matrix : matrix protease . This role matrix proteolysis modulator associate function cell migration regulator give protein anticancer role . The antitumor property LRP-1 demonstrate thyroid cancer vitro . In study , loss LRP-1 expression decrease LRP-1 activity correlate increase cancer cell migration invasion . However , opposite effect observe prostate cancer cell line . The clinical impact level LRP-1 expression overall survival cancer patient assess two study : one patient suffer hepatocellular carcinoma one patient suffer primitive lung adenocarcinoma . In study , decrease immunohistochemical gene expression LRP-1 correlate overall survival decrease . In CRC , one immunohistochemical expression study LRP-1 publish date . This study show adenocarcinomatous cell express LRP-1 , nearly half case , weak normal colonic cell . The clinical prognostic impact LRP-1 expression colon cancer association particular molecular morphological profile study date . In work , investigator study immunohistochemical genic expression LRP-1 well-characterized series CRC . The main objective study study genic immunohistochemical approach role LRP-1 aggressiveness colon adenocarcinoma . The secondary objective study search association LRP-1 expression level morphological molecular profile colonic adenocarcinoma This study first explore expression LRP-1 well characterize colon cancer different morphological molecular profile . This study help increase knowledge prognostic role LRP-1 colon cancer possible association clinical , morphological molecular parameter . There retrospective cohort study , single center . The investigator first design list eligible patient use request software DIAMIC th pathology department component code `` colon '' , damage code `` adenocarcinoma `` period `` 2006 2012 '' . Patients suffer Lynch syndrome familial cancer syndrome exclude study . Informed consent send select patient . Once patient list complete : - The patient ' medical record review : sociodemographic clinical data colonic tumor location , presence synchronous metastasis , treatment type duration , patient follow date 01/06/2014 point ( metastasis occurrence , disease recurrence , patient death , ... ) . - A central review pathological slide perform criterion : adenocarcinoma subtype accord WHO 2010 classification , differentiation , association polyp type , pTNM stage , invasion front budding , stroma type , presence amount tumor necrosis ) . - Immunohistochemical analysis formalin fix paraffin embed tissue perform : - qualitative semi-quantitative evaluation LRP1 immunoexpression anti-5A6 8G1 antibody - RER phenotype research ( MLH1 , MSH2 , MSH6 PMS2 immunohistochemistry ) BRAF V600E immunohistochemistry - Molecular analyzes : - analysis LRP-1 gene expression frozen tissue - select case : search microsatellite instability , search BRAF V600E , KRAS ( exon 2 , 3 4 ) NRAS ( exon 2 , 3 4 ) mutation formalin fix paraffin embed tissue Statistical analysis : - Data description : mean standard deviation quantitative variable ; number percentage categorical variable . - Comparison tumor high expression LRP-1 tumor little express LRP-1 univariate analysis ( Student 's test Wilcoxon test , Chi2 Fisher 's exact ) multivariate ( logistic regression ) . - Search factor associate patient outcome , include expression LRP1 , univariate analysis ( log-rank test ) multivariate ( Cox model ) . Colorectal cancer ( CRC ) major public health problem France worldwide . CRC third common cancer incidence mortality France . The vast majority cancer adenocarcinomas arise sporadically develop precursor lesion : adenoma . All CRC disease stage prognosis . Various parameter identify factor influence prognosis allow adjustment treatment . The poor histoprognostic factor presence tumor vessel nerve invasion mucinous adenocarcinoma subtype . At molecular level , presence microsatellite instability ( MSI ) improve prognosis , presence BRAF mutation independent poor prognostic factor . Low density lipoprotein relate Protein Receptor 1 ( LRP-1 ) multifunctional endocytic receptor belongs family LDL receptor . He involve clearance enzyme responsible degradation extracellular matrix : matrix protease . This role matrix proteolysis modulator associate function cell migration regulator give protein anticancer role . The antitumor property LRP-1 demonstrate thyroid cancer vitro . In study , loss LRP-1 expression decrease LRP-1 activity correlate increase cancer cell migration invasion . However , opposite effect observe prostate cancer cell line . The clinical impact level LRP-1 expression overall survival cancer patient assess two study : one patient suffer hepatocellular carcinoma one patient suffer primitive lung adenocarcinoma . In study , decrease immunohistochemical gene expression LRP-1 correlate overall survival decrease . In CRC , one immunohistochemical expression study LRP-1 publish date . This study show adenocarcinomatous cell express LRP-1 , nearly half case , weak normal colonic cell . The clinical prognostic impact LRP-1 expression colon cancer association particular molecular morphological profile study date . In work , investigator study immunohistochemical genic expression LRP-1 well-characterized series CRC . The main objective study study genic immunohistochemical approach role LRP-1 aggressiveness colon adenocarcinoma . The secondary objective study search association LRP-1 expression level morphological molecular profile colonic adenocarcinoma This study first explore expression LRP-1 well characterize colon cancer different morphological molecular profile . This study help increase knowledge prognostic role LRP-1 colon cancer possible association clinical , morphological molecular parameter . There retrospective cohort study , single center . The investigator first design list eligible patient use request software DIAMIC th pathology department component code `` colon '' , damage code `` adenocarcinoma `` period `` 2006 2012 '' . Patients suffer Lynch syndrome familial cancer syndrome exclude study . Informed consent send select patient . Once patient list complete : - The patient ' medical record review : sociodemographic clinical data colonic tumor location , presence synchronous metastasis , treatment type duration , patient follow date 01/06/2014 point ( metastasis occurrence , disease recurrence , patient death , ... ) . - A central review pathological slide perform criterion : adenocarcinoma subtype accord WHO 2010 classification , differentiation , association polyp type , pTNM stage , invasion front budding , stroma type , presence amount tumor necrosis ) . - Immunohistochemical analysis formalin fix paraffin embed tissue perform : - qualitative semi-quantitative evaluation LRP1 immunoexpression anti-5A6 8G1 antibody - RER phenotype research ( MLH1 , MSH2 , MSH6 PMS2 immunohistochemistry ) BRAF V600E immunohistochemistry - Molecular analyzes : - analysis LRP-1 gene expression frozen tissue - select case : search microsatellite instability , search BRAF V600E , KRAS ( exon 2 , 3 4 ) NRAS ( exon 2 , 3 4 ) mutation formalin fix paraffin embed tissue Statistical analysis : - Data description : mean standard deviation quantitative variable ; number percentage categorical variable . - Comparison tumor high expression LRP-1 tumor little express LRP-1 univariate analysis ( Student 's test Wilcoxon test , Chi2 Fisher 's exact ) multivariate ( logistic regression ) . - Search factor associate patient outcome , include expression LRP1 , univariate analysis ( log-rank test ) multivariate ( Cox model ) .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>patient operate colon adenocarcinoma infiltrate stage II least operated Chu Reims 01/01/2006 31/12/2012 give consent study receive treatment neoadjuvant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>